Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - April 2005

  1. Elimination of Rubella and Congenital Rubella Syndrome--United States, 1969-2004.   MMWR Morb Mortal Wkly Rep; 54 (11): 279-282; March 25, 2005.

  2. Varicella Surveillance in Public Elementary Schools--Multnomah County, Oregon, 2002-2004.   MMWR Morb Mortal Wkly Rep; 54 (11): 274-276; March 25, 2005.

  3. Varicella-Related Deaths--United States, January 2003-June 2004.   MMWR Morb Mortal Wkly Rep; 54 (11): 272-274; March 25, 2005.

  4. Winter's a Wonderland, but Dangerous, Too. Mortality Rates Go Up During the Next Few Months. To Stay Healthy, Stay Warm and Vaccinated--and Install Carbon Monoxide Detectors.   Harv Health Lett; 30 (3): 4-5; January, 2005.

  5. [Effects of Vaccination Against Influenza on Progression of Chronic Obstructive Pulmonary Diseases].Ter Arkh; 77 (1): 59-62; 2005.

  6. Hospital Initiative Sees Higher Vaccination Rates.   Hosp Case Manag; 13 (3): 44-45; March, 2005.

  7. Progress in Reducing Measles Mortality--Worldwide, 1999-2003.  MMWR Morb Mortal Wkly Rep; 54 (8): 200-203; March 4, 2005.

  8. Vaccination Coverage Among Callers to a State Influenza Hotline--Connecticut, 2004-05 Influenza Season. MMWR Morb Mortal Wkly Rep; 54 (8): 199-200; March 4, 2005.

  9. Interventions to Increase Influenza Vaccination of Health-Care Workers--California and Minnesota.  MMWR Morb Mortal Wkly Rep; 54 (8): 196-199; March 4, 2005.

  10. Ada, G.  Overview of Vaccines and Vaccination.  Mol Biotechnol; 29 (3): 255-272; March, 2005.

  11. Baggs, J.; Chen, R. T.; Damon, I. K.; Rotz, L.; Allen, C.; Fullerton, K. E.; Casey, C.; Nordenberg, D.; Mootrey, G.  Safety Profile of Smallpox Vaccine: Insights From the Laboratory Worker Smallpox Vaccination Program.  Clin Infect Dis; 40 (8): 1133-1140; April 15, 2005.

  12. Bechir, M.; Schelling, E.; Wyss, K.; Daugla, D. M.; Daoud, S.; Tanner, M.; Zinsstag, J.  [An Innovative Approach Combining Human and Animal Vaccination Campaigns in Nomadic Settings of Chad: Experiences and Costs].   Med Trop (Mars); 64 (5): 497-502; 2004.

  13. Bogaert, D.; Veenhoven, R. H.; Ramdin, R.; Luijendijk, I. H.; Rijkers, G. T.; Sanders, E. A.; de, Groot R.; Hermans, P. W.   Pneumococcal Conjugate Vaccination Does Not Induce a Persisting Mucosal IgA Response in Children With Recurrent Acute Otitis Media.   Vaccine; 23 (20): 2607-2613; April 8, 2005.

  14. Bompart, F.  Vaccination Strategies for the Last Stages of Global Polio Eradication.   Indian Pediatr; 42 (2): 163-169; February, 2005.

  15. Bronstein, D. E.; Cotliar, J.; Votava-Smith, J. K.; Powell, M. Z.; Miller, M. J.; Cherry, J. D.  Recurrent Papular Urticaria After Varicella Immunization in a Fifteen-Month-Old Girl.   Pediatr Infect Dis J; 24 (3): 269-270; March, 2005.

  16. Brotherton, J.; McIntyre, P.; Puech, M.; Wang, H.; Gidding, H.; Hull, B.; Lawrence, G.; MacIntyre, R.; Wood, N.; Armstrong, D.  Vaccine Preventable Diseases and Vaccination Coverage in Australia 2001 to 2002.   Commun Dis Intell; 28 (Suppl 2): vii-S116; December, 2004.

  17. Bursztyn, M.  Vascular Events After Acute Infection or Vaccination.   N Engl J Med; 352 (11): 1151-1153; March 17, 2005.

  18. Castillo-Febres, O.; Lopez, G.; Ortegal, F.; Estopinan, M.; Casanova-Escalona, L.; Sanchez-Naveda, M.; Decker, M.; Edwards, K. M.  [Oropharyngeal Carriers in Venezuelan Children in Two Child Care Settings, Vaccinated or Not With Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine (PRP-T)]. Invest Clin; 46 (1): 15-24; March, 2005.

  19. Czaja, C.; Crossette, L.; Metlay, J. P.  Accuracy of Adult Reported Pneumococcal Vaccination Status of Children.    Ann Epidemiol; 15 (4): 253-256; April, 2005.

  20. De, Serres G.; Duval, B.  Pertussis Vaccination Beyond Childhood.   Lancet; 365 (9464): 1015-1016; March 16, 2005.

  21. Ehreth, J.  The Economics of Vaccination From a Global Perspective: Present and Future.   Expert Rev Vaccines; 4 (1): 19-21; February, 2005.

  22. Erickson, L. J.; De, Wals P.; Farand, L.  An Analytical Framework for Immunization Programs in Canada.   Vaccine; 23 (19): 2470-2476; March 31, 2005.

  23. Fatovic-Ferencic, S.; Buklijas, T.  Vaccination: Fascination and Poetry.    Croat Med J; 46 (1): 148-149; February, 2005.

  24. Fiscella, K.  Commentary-Anatomy of Racial Disparity in Influenza Vaccination.   Health Serv Res; 40 (2): 539-550; April, 2005.

  25. Gabutti, G.; Guido, M.; Quattrocchi, M.; Zizza, A.; De, Donno A.; Gasparini, R.; Donatelli, I.; Prato, R.; Germinario, C.; Crovari, P.  Surveillance of Influenza in Apulia, Italy, 1999-2000, 2000-2001, 2001-2002, and 2002-2003 Seasons.   Med Mal Infect; 34 (10): 469-476; October, 2004.

  26. Geier, D.; Geier, M. R.  Neurodevelopmental Disorders Following Thimerosal-Containing Childhood Immunizations: a Follow-Up Analysis.   Int J Toxicol; 23 (6): 369-376; November, 2004.

  27. Gill, T.; Taylor, A. W.; Kempe, A.; Pickering, S.; Watson, M.  Prevalence of Influenza Vaccination in South Australian Aged Care Homes.   Aust N Z J Public Health; 29 (1): 38-43; February, 2005.

  28. Gindi, M.; Oravitz, P.; Sexton, R.; Shpak, M.; Eisenhart, A.  Unreliability of Reported Tetanus Vaccination Histories.   Am J Emerg Med; 23 (2): 120-122; March, 2005.

  29. Grabowsky, M.; Nobiya, T.; Ahun, M.; Donna, R.; Lengor, M.; Zimmerman, D.; Ladd, H.; Hoekstra, E.; Bello, A.; Baffoe-Wilmot, A.; Amofah, G.  Distributing Insecticide-Treated Bednets During Measles Vaccination: a Low-Cost Means of Achieving High and Equitable Coverage.   Bull World Health Organ; 83 (3): 195-201; March, 2005.

  30. Greig, J. E.; Patel, M. S.; Clements, M. S.; Taylor, N. K.  Control Strategies for Q Fever Based on Results of Pre-Vaccination Screening in Victoria, 1988 to 2001.   Aust N Z J Public Health; 29 (1): 53-57; February, 2005.

  31. Gutierrez, Hernando R.; Alvarez, Pasquin M.; Sesmero, Lillo M.; Martin, Martin S.  [Vaccination of Immigrant Children: How Do They Reach Our Clinics?].   Aten Primaria; 35 (3): 164; February 28, 2005.

  32. Hallauer, J. F.; Neuschaefer-Rube, N.  Influenza Vaccination of Hospital Staff in Germany: a Five-Year Survey on Vaccination Coverage and Policies: Identified Deficits in Influenza Immunisation Campaigns for Hospital Employees.   Soz Praventivmed; 50 (1): 38-44; 2005.

  33. Hanna, J. N.; Bullen, R. C.; Andrews, D. E.  The Acceptance of Three Simultaneous Vaccine Injections Recommended at 12 Months of Age.   Commun Dis Intell; 28 (4): 493-496; 2004.

  34. Hebert, P. L.; Frick, K. D.; Kane, R. L.; McBean, A. M.  The Causes of Racial and Ethnic Differences in Influenza Vaccination Rates Among Elderly Medicare Beneficiaries.   Health Serv Res; 40 (2): 517-538; April, 2005.

  35. Hewlett, E. L.; Edwards, K. M.  Clinical Practice. Pertussis--Not Just for Kids.   N Engl J Med; 352 (12): 1215-1222; March 24, 2005.

  36. Horby, P. W.; Williams, A.; Burgess, M. A.; Wang, H.  Prevalence and Determinants of Influenza Vaccination in Australians Aged 40 Years and Over--a National Survey.   Aust N Z J Public Health; 29 (1): 35-37; February, 2005.

  37. Hoyle, T.  What Information Should Be Integrated With the Childhood Immunization Registry?   Mich Med; 104 (1): 18-19; January, 2005.

  38. Kaiser, J.  Biodefense. Report Faults Smallpox Vaccination.   Science; 307 (5715): 1540; March 11, 2005.

  39. Keane, M. T.; Walter, M. V.; Patel, B. I.; Moorthy, S.; Stevens, R. B.; Bradley, K. M.; Buford, J. F.; Anderson, E. L.; Anderson, L. P.; Tibbals, K.; Vernon, T. M.  Confidence in Vaccination: a Parent Model.   Vaccine; 23 (19): 2486-2493; March 31, 2005.

  40. Kilbourne, E. D.  Intradermal Vaccination Against Influenza.   N Engl J Med; 352 (10): 1044-1046; March 10, 2005.

  41. Koch, D.; Thompson, L.; Swart, B.  Looking Ahead to Successful Immunization Programs.   Can Nurse; 101 (2): 14-15; February, 2005.

  42. Kumar, A.; Murray, D. L.; Havlichek, D. H.   Immunizations for the College Student: a Campus Perspective of an Outbreak and National and International Considerations.   Pediatr Clin North Am; 52 (1): 229-41, xi; February, 2005.

  43. Lambert, S.; O'Grady, K. A.; Gabriel, S.; Carter, R.; Nolan, T.  The Cost of Seasonal Respiratory Illnesses in Australian Children: the Dominance of Patient and Family Costs and Implications for Vaccine Use.   Commun Dis Intell; 28 (4): 510-516; 2004.

  44. Lawrence, G.; Boyd, I.  Surveillance of Adverse Events Following Immunisation for Children Aged Less Than 7 Years, 1 January to 30 June 2004.   Commun Dis Intell; 28 (4): 490-492; 2004.

  45. Levi, B. H.; Brown, G.  Description of the Immunization Information Database: a Tool for Investigating Allegations Made Against Childhood Immunizations. Vaccine; 23 (16): 2009-2015; March 14, 2005.

  46. Machado, C. M.; de, Souza, V; Sumita, L. M.; da, Rocha, I; Dulley, F. L.; Pannuti, C. S.  Early Measles Vaccination in Bone Marrow Transplant Recipients.   Bone Marrow Transplant; 35 (8): 787-791; March 7, 2005.

  47. Manian, F. A.  Intradermal Vaccination Against Influenza.   N Engl J Med; 352 (10): 1044-1046; March 10, 2005.

  48. Maubec, E.; Pinquier, L.; Viguier, M.; Caux, F.; Amsler, E.; Aractingi, S.; Chafi, H.; Janin, A.; Cayuela, J. M.; Dubertret, L.; Authier, F. J.; Bachelez, H.  Vaccination-Induced Cutaneous Pseudolymphoma.   J Am Acad Dermatol; 52 (4): 623-629; April, 2005.

  49. Miron, D.; Lavi, I.; Kitov, R.; Hendler, A.  Vaccine Effectiveness and Severity of Varicella Among Previously Vaccinated Children During Outbreaks in Day-Care Centers With Low Vaccination Coverage. Pediatr Infect Dis J; 24 (3): 233-236; March, 2005.

  50. Mitchell, V.; Walker, D.; Zuber, P.; Lydon, P.; Ahun, M.  Evidenced-Based Decision Making About Hib Vaccination.    Lancet; 365 (9463): 936-937; March 9, 2005.

  51. Munoz-Lope, F.  Vaccination. Yes or No?   Allergol Immunopathol (Madr); 33 (1): 1-6; January, 2005.

  52. Navas, E.; Salleras, L.; Gisbert, R.; Dominguez, A.; Timoner, E.; Ibanez, D.; Prat, A.  Cost-Benefit and Cost-Effectiveness of the Incorporation of the Pneumococcal 7-Valent Conjugated Vaccine in the Routine Vaccination Schedule of Catalonia (Spain).   Vaccine; 23 (17-18): 2342-2348; March 18, 2005.

  53. Nicholls, S.; Carroll, K.; Crofts, J.; Ben-Eliezer, E.; Paul, J.; Zambon, M.; Joseph, C. A.; Verlander, N. Q.; Goddard, N. L.; Watson, J. M.  Outbreak of Influenza A (H3N2) in a Highly-Vaccinated Religious Community: a Retrospective Cohort Study.   Commun Dis Public Health; 7 (4): 272-277; December, 2004.

  54. Oh, R. C.  Folliculitis After Smallpox Vaccination: a Report of Two Cases.   Mil Med; 170 (2): 133-136; February, 2005.

  55. Ohkusa, Y.  Policy Evaluation for the Subsidy for Influenza Vaccination in Elderly.   Vaccine; 23 (17-18): 2256-2260; March 18, 2005.

  56. Ohrui, T.; Nakayama, K.; Fukushima, T.; Chiba, H.; Sasaki, H.  [Prevention of Elderly Pneumonia by Pneumococcal, Influenza and BCG Vaccinations].   Nippon Ronen Igakkai Zasshi; 42 (1): 34-36; January, 2005.

  57. Olsen, G. W.; Steinberg, M. E.; Ley, C. A.   Worksite Influenza Immunization Programs. Insight into the Implementation and Cost-Benefit.   AAOHN J; 53 (3): 105-110; March, 2005.

  58. Patel, R.; Longini, I. M., Jr.; Halloran, M. E.  Finding Optimal Vaccination Strategies for Pandemic Influenza Using Genetic Algorithms.   J Theor Biol; 234 (2): 201-212; May 21, 2005.

  59. Phillips, A. C.; Carroll, D.; Burns, V. E.; Drayson, M.  Neuroticism, Cortisol Reactivity, and Antibody Response to Vaccination.  Psychophysiology; 42 (2): 232-238; March, 2005.

  60. Poland, G. A.; Tosh, P.; Jacobson, R. M.  Requiring Influenza Vaccination for Health Care Workers: Seven Truths We Must Accept.   Vaccine; 23 (17-18): 2251-2255; March 18, 2005.

  61. Poland, G. A.; Grabenstein, J. D.; Neff, J. M.  The US Smallpox Vaccination Program: a Review of a Large Modern Era Smallpox Vaccination Implementation Program.   Vaccine; 23 (17-18): 2078-2081; March 18, 2005.

  62. Rock, M. T.; Yoder, S. M.; Wright, P. F.; Talbot, T. R.; Edwards, K. M.; Crowe, J. E., Jr.  Differential Regulation of Granzyme and Perforin in Effector and Memory T Cells Following Smallpox Immunization.   J Immunol; 174 (6): 3757-3764; March 15, 2005.

  63. Root-Bernstein, R. S.  Vaccination Markers: Designing Unique Antigens to Be Added to Vaccines to Differentiate Between Natural Infection and Vaccination.   Vaccine; 23 (17-18): 2057-2059; March 18, 2005.

  64. Schwartz, B.; Gellin, B.  Vaccination Strategies for an Influenza Pandemic.   J Infect Dis; 191 (8): 1207-1209; April 15, 2005.

  65. Schwarz, Chavarri H.; Ortuno Lopez, J. L.; Lattur, Vilchez A.; Pedrera, Carbonell, V; Orozco, Beltran D.; Gil, Guillen, V  [Can We Improve Influenza Vaccination Rates in Older People With Chronic Diseases?].   Aten Primaria; 35 (4): 178-182; March 15, 2005.

  66. Sharifi, N.; Mofrad, P. S.  Vascular Events After Acute Infection or Vaccination.   N Engl J Med; 352 (11): 1151-1153; March 17, 2005.

  67. Shatz, D. V.  Vaccination Considerations in the Asplenic Patient. Expert Rev Vaccines; 4 (1): 27-34; February, 2005.

  68. Slifka, M. K.  The Future of Smallpox Vaccination: Is MVA the Key?  Med Immunol; 4 (1): 2; March 1, 2005.

  69. Smith, P. J.; Hoaglin, D. C.; Battaglia, M. P.; Khare, M.; Barker, L. E.  Statistical Methodology of the National Immunization Survey, 1994-2002.   Vital Health Stat 2;(138): 1-55; March, 2005.

  70. Sokos, D. R.  Pharmacists' Role in Increasing Pneumococcal and Influenza Vaccination.   Am J Health Syst Pharm; 62 (4): 367-377; February 15, 2005.

  71. Stephenson, I.; Bugarini, R.; Nicholson, K. G.; Podda, A.; Wood, J. M.; Zambon, M. C.; Katz, J. M.  Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses After Vaccination With Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy.   J Infect Dis; 191 (8): 1210-1215; April 15, 2005.

  72. Szucs, T. D.  Health Economic Research on Vaccinations and Immunisation Practices--an Introductory Primer.   Vaccine; 23 (17-18): 2095-2103; March 18, 2005.

  73. Victora, C. G.  Reaching the Underserved.   Am J Public Health; 95 (2): 195; February, 2005.

  74. Wang, S. T.; Lee, L. T.; Chen, L. S.; Chen, T. H.  Economic Evaluation of Vaccination Against Influenza in the Elderly: an Experience From a Population-Based Influenza Vaccination Program in Taiwan. Vaccine; 23 (16): 1973-1980; March 14, 2005.

  75. Watson, M.; Roche, P.; Bayley, K.; Bell, J. M.; Collignon, P.; Gilbert, G. L.; Hogg, G.; Keil, A. D.; Krause, V.; Murphy, D.; Smith, H. V.; Brown, M.; Stylianopoulos, J.; Turnidge, J.  Laboratory Surveillance of Invasive Pneumococcal Disease in Australia, 2003 Predicting the Future Impact of the Universal Childhood Conjugate Vaccine Program. Commun Dis Intell; 28 (4): 455-464; 2004.

  76. Waugh, N.  Commentary: Pneumococcal Immunization May Not Be Cost-Effective in the Elderly in Developed Countries.   Int J Epidemiol; March 11, 2005. [Epub ahead of print]

  77. Weller, T. H.  Intradermal Vaccination Against Influenza.   N Engl J Med; 352 (10): 1044-1046; March 10, 2005.

  78. Wilson, S. J.  Factors Affecting Implementation of the U.S. Smallpox Vaccination Program, 2003.   Public Health Rep; 120 (1): 3-5; January, 2005.

Back to Top